nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—MAPK3—optic choroid—age related macular degeneration	0.0687	0.205	CbGeAlD
Arsenic trioxide—CCND1—eye—age related macular degeneration	0.0185	0.0553	CbGeAlD
Arsenic trioxide—CCND1—retina—age related macular degeneration	0.0184	0.0548	CbGeAlD
Arsenic trioxide—CCND1—connective tissue—age related macular degeneration	0.0179	0.0533	CbGeAlD
Arsenic trioxide—MAPK1—eye—age related macular degeneration	0.0156	0.0466	CbGeAlD
Arsenic trioxide—MAPK1—connective tissue—age related macular degeneration	0.015	0.0449	CbGeAlD
Arsenic trioxide—TXNRD1—eye—age related macular degeneration	0.0145	0.0434	CbGeAlD
Arsenic trioxide—TXNRD1—retina—age related macular degeneration	0.0144	0.043	CbGeAlD
Arsenic trioxide—TXNRD1—connective tissue—age related macular degeneration	0.014	0.0418	CbGeAlD
Arsenic trioxide—MAPK3—eye—age related macular degeneration	0.0138	0.0413	CbGeAlD
Arsenic trioxide—MAPK3—retina—age related macular degeneration	0.0137	0.0409	CbGeAlD
Arsenic trioxide—MAPK3—connective tissue—age related macular degeneration	0.0133	0.0398	CbGeAlD
Arsenic trioxide—AKT1—eye—age related macular degeneration	0.013	0.0389	CbGeAlD
Arsenic trioxide—AKT1—retina—age related macular degeneration	0.0129	0.0386	CbGeAlD
Arsenic trioxide—AKT1—connective tissue—age related macular degeneration	0.0126	0.0375	CbGeAlD
Arsenic trioxide—JUN—eye—age related macular degeneration	0.0113	0.0339	CbGeAlD
Arsenic trioxide—JUN—retina—age related macular degeneration	0.0112	0.0336	CbGeAlD
Arsenic trioxide—JUN—connective tissue—age related macular degeneration	0.0109	0.0326	CbGeAlD
Arsenic trioxide—IKBKB—connective tissue—age related macular degeneration	0.0109	0.0325	CbGeAlD
Arsenic trioxide—CYP1B1—eye—age related macular degeneration	0.00605	0.0181	CbGeAlD
Arsenic trioxide—CYP1B1—connective tissue—age related macular degeneration	0.00583	0.0174	CbGeAlD
Arsenic trioxide—ABCB1—retina—age related macular degeneration	0.0022	0.00657	CbGeAlD
Arsenic trioxide—AKT1—Signaling by GPCR—RHO—age related macular degeneration	0.000445	0.000669	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CFI—age related macular degeneration	0.000444	0.000667	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000439	0.00066	CbGpPWpGaD
Arsenic trioxide—AKT1—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.000436	0.000656	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—C2—age related macular degeneration	0.000433	0.000652	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000432	0.000649	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—RHO—age related macular degeneration	0.000431	0.000649	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ABCA4—age related macular degeneration	0.000431	0.000648	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CFHR3—age related macular degeneration	0.000431	0.000648	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RDH8—age related macular degeneration	0.000429	0.000645	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NMNAT1—age related macular degeneration	0.000426	0.000641	CbGpPWpGaD
Arsenic trioxide—MAPK3—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.000423	0.000636	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ABCA4—age related macular degeneration	0.000418	0.000629	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—C2—age related macular degeneration	0.000416	0.000626	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RDH8—age related macular degeneration	0.000416	0.000625	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CFHR3—age related macular degeneration	0.000412	0.00062	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by VEGF—VEGFA—age related macular degeneration	0.000412	0.000619	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—RHO—age related macular degeneration	0.00041	0.000617	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—C2—age related macular degeneration	0.000404	0.000607	CbGpPWpGaD
Arsenic trioxide—MAPK1—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.000403	0.000606	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by VEGF—VEGFA—age related macular degeneration	0.0004	0.000601	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ABCA4—age related macular degeneration	0.000398	0.000598	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RDH8—age related macular degeneration	0.000396	0.000595	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RPE65—age related macular degeneration	0.00039	0.000586	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000388	0.000583	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—C2—age related macular degeneration	0.000384	0.000578	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by VEGF—VEGFA—age related macular degeneration	0.00038	0.000572	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RDH8—age related macular degeneration	0.000379	0.000569	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—RHO—age related macular degeneration	0.000375	0.000564	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RPE65—age related macular degeneration	0.000375	0.000563	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ELOVL4—age related macular degeneration	0.000373	0.00056	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—C2—age related macular degeneration	0.000368	0.000553	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—RHO—age related macular degeneration	0.000364	0.000547	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RPE65—age related macular degeneration	0.000363	0.000546	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CFH—age related macular degeneration	0.000363	0.000545	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—SLC16A8—age related macular degeneration	0.000361	0.000543	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000354	0.000532	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CFB—age related macular degeneration	0.000352	0.000529	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CFH—age related macular degeneration	0.000348	0.000524	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—RHO—age related macular degeneration	0.000346	0.000521	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RPE65—age related macular degeneration	0.000346	0.00052	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000345	0.000519	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000345	0.000518	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CFH—age related macular degeneration	0.000338	0.000508	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CFB—age related macular degeneration	0.000338	0.000508	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.000336	0.000505	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000333	0.000501	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000331	0.000498	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000331	0.000498	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RPE65—age related macular degeneration	0.000331	0.000497	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CFB—age related macular degeneration	0.000328	0.000493	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CFH—age related macular degeneration	0.000321	0.000483	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000321	0.000483	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—KDR—age related macular degeneration	0.000317	0.000476	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000315	0.000474	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000315	0.000474	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ABCA4—age related macular degeneration	0.000314	0.000473	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—CD36—age related macular degeneration	0.000313	0.00047	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CFB—age related macular degeneration	0.000312	0.000469	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.000309	0.000465	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CFH—age related macular degeneration	0.000308	0.000462	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000306	0.00046	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ABCA4—age related macular degeneration	0.000302	0.000454	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—KDR—age related macular degeneration	0.000301	0.000453	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—SLC16A8—age related macular degeneration	0.0003	0.000451	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CFB—age related macular degeneration	0.000298	0.000448	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ABCA4—age related macular degeneration	0.000293	0.00044	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000291	0.000438	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—VEGFA—age related macular degeneration	0.000287	0.000431	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000286	0.00043	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ABCA4—age related macular degeneration	0.000279	0.000419	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—APOE—age related macular degeneration	0.000276	0.000415	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—VEGFA—age related macular degeneration	0.000276	0.000414	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000275	0.000413	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RHO—age related macular degeneration	0.000273	0.000411	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—CD36—age related macular degeneration	0.00027	0.000405	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ABCA4—age related macular degeneration	0.000267	0.000401	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000266	0.0004	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—CD36—age related macular degeneration	0.000264	0.000398	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RHO—age related macular degeneration	0.000263	0.000395	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000263	0.000395	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.000262	0.000395	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—CD36—age related macular degeneration	0.000261	0.000393	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—CD36—age related macular degeneration	0.000256	0.000386	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RHO—age related macular degeneration	0.000255	0.000383	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—VEGFA—age related macular degeneration	0.000254	0.000383	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000253	0.000381	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—CD36—age related macular degeneration	0.000249	0.000374	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD36—age related macular degeneration	0.000248	0.000373	CbGpPWpGaD
Arsenic trioxide—AKT1—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000244	0.000367	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—CD36—age related macular degeneration	0.000244	0.000367	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RHO—age related macular degeneration	0.000242	0.000365	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD36—age related macular degeneration	0.000238	0.000358	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000237	0.000356	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—C3—age related macular degeneration	0.000235	0.000353	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CST3—age related macular degeneration	0.000235	0.000353	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—KDR—age related macular degeneration	0.000233	0.00035	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RHO—age related macular degeneration	0.000232	0.000349	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD36—age related macular degeneration	0.000231	0.000347	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000229	0.000345	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD36—age related macular degeneration	0.000229	0.000344	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CST3—age related macular degeneration	0.000228	0.000342	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000227	0.000342	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—KDR—age related macular degeneration	0.000226	0.00034	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—C3—age related macular degeneration	0.000226	0.000339	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000225	0.000339	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CRP—age related macular degeneration	0.000223	0.000336	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—VEGFA—age related macular degeneration	0.000221	0.000332	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD36—age related macular degeneration	0.00022	0.00033	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—C3—age related macular degeneration	0.000219	0.000329	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—C3—age related macular degeneration	0.000217	0.000326	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CST3—age related macular degeneration	0.000217	0.000326	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—SQSTM1—age related macular degeneration	0.000215	0.000324	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—KDR—age related macular degeneration	0.000215	0.000323	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CRP—age related macular degeneration	0.000215	0.000323	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—TLR4—age related macular degeneration	0.000214	0.000322	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000213	0.00032	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFBR1—age related macular degeneration	0.000211	0.000317	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD36—age related macular degeneration	0.00021	0.000316	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00021	0.000315	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—C3—age related macular degeneration	0.000208	0.000313	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CRP—age related macular degeneration	0.000208	0.000313	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—SQSTM1—age related macular degeneration	0.000207	0.000311	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—TLR4—age related macular degeneration	0.000206	0.000309	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—VEGFA—age related macular degeneration	0.000206	0.000309	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000205	0.000308	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFBR1—age related macular degeneration	0.000204	0.000307	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD36—age related macular degeneration	0.000202	0.000303	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—SQSTM1—age related macular degeneration	0.000201	0.000302	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.0002	0.000301	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—TLR4—age related macular degeneration	0.0002	0.0003	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—C3—age related macular degeneration	0.000199	0.000299	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CRP—age related macular degeneration	0.000198	0.000298	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—VEGFA—age related macular degeneration	0.000196	0.000294	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFBR1—age related macular degeneration	0.000194	0.000292	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—C3—age related macular degeneration	0.000191	0.000288	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—SQSTM1—age related macular degeneration	0.000191	0.000287	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—TLR4—age related macular degeneration	0.00019	0.000286	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CRP—age related macular degeneration	0.000189	0.000285	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—C3—age related macular degeneration	0.000185	0.000278	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—LIPC—age related macular degeneration	0.000185	0.000278	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.000185	0.000278	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000183	0.000275	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—SQSTM1—age related macular degeneration	0.000183	0.000275	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—TLR4—age related macular degeneration	0.000182	0.000273	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CETP—age related macular degeneration	0.000178	0.000268	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000177	0.000265	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—VEGFA—age related macular degeneration	0.000174	0.000262	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—APOE—age related macular degeneration	0.000172	0.000259	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—KDR—age related macular degeneration	0.000169	0.000254	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—VEGFA—age related macular degeneration	0.000166	0.00025	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—C3—age related macular degeneration	0.000158	0.000238	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000156	0.000234	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—LIPC—age related macular degeneration	0.000154	0.000231	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFBR1—age related macular degeneration	0.000154	0.000231	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CETP—age related macular degeneration	0.000148	0.000223	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000148	0.000222	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000148	0.000222	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CCL2—age related macular degeneration	0.000145	0.000218	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD36—age related macular degeneration	0.000144	0.000217	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—C3—age related macular degeneration	0.000144	0.000216	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000143	0.000215	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—C3—age related macular degeneration	0.000139	0.00021	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SQSTM1—age related macular degeneration	0.000139	0.000209	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD36—age related macular degeneration	0.000139	0.000208	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—C3—age related macular degeneration	0.000137	0.000206	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000136	0.000205	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD36—age related macular degeneration	0.000134	0.000202	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000134	0.000201	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—C3—age related macular degeneration	0.000133	0.0002	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—C3—age related macular degeneration	0.000131	0.000198	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFBR1—age related macular degeneration	0.00013	0.000196	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—age related macular degeneration	0.00013	0.000196	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00013	0.000195	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000129	0.000194	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—VEGFA—age related macular degeneration	0.000128	0.000193	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD36—age related macular degeneration	0.000128	0.000192	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—C3—age related macular degeneration	0.000127	0.000192	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—VEGFA—age related macular degeneration	0.000126	0.000189	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—age related macular degeneration	0.000125	0.000188	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TLR4—age related macular degeneration	0.000125	0.000188	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—VEGFA—age related macular degeneration	0.000124	0.000187	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000123	0.000186	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000123	0.000185	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD36—age related macular degeneration	0.000122	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—VEGFA—age related macular degeneration	0.000122	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—C3—age related macular degeneration	0.000121	0.000182	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—age related macular degeneration	0.000121	0.000182	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TLR4—age related macular degeneration	0.00012	0.00018	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—age related macular degeneration	0.000118	0.000178	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SQSTM1—age related macular degeneration	0.000118	0.000178	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TLR4—age related macular degeneration	0.000116	0.000175	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—age related macular degeneration	0.000116	0.000175	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—C3—age related macular degeneration	0.000116	0.000174	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—age related macular degeneration	0.000115	0.000173	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—APOE—age related macular degeneration	0.000113	0.00017	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000113	0.00017	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCL2—age related macular degeneration	0.000113	0.000169	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000112	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TLR4—age related macular degeneration	0.000111	0.000166	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—age related macular degeneration	0.00011	0.000166	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APOE—age related macular degeneration	0.00011	0.000165	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCL2—age related macular degeneration	0.000109	0.000164	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000109	0.000163	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CD36—age related macular degeneration	0.000107	0.000161	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TLR4—age related macular degeneration	0.000106	0.000159	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APOE—age related macular degeneration	0.000104	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCL2—age related macular degeneration	0.000104	0.000156	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—LIPC—age related macular degeneration	9.47e-05	0.000142	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—APOE—age related macular degeneration	9.46e-05	0.000142	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—age related macular degeneration	9.3e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CETP—age related macular degeneration	9.13e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	9.1e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CD36—age related macular degeneration	8.91e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—C3—age related macular degeneration	8.84e-05	0.000133	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—C3—age related macular degeneration	8.5e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—C3—age related macular degeneration	8.24e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOE—age related macular degeneration	8.23e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KDR—age related macular degeneration	8.06e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOE—age related macular degeneration	7.91e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOE—age related macular degeneration	7.86e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—C3—age related macular degeneration	7.84e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KDR—age related macular degeneration	7.75e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOE—age related macular degeneration	7.67e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LIPC—age related macular degeneration	7.56e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KDR—age related macular degeneration	7.52e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—C3—age related macular degeneration	7.5e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOE—age related macular degeneration	7.3e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CETP—age related macular degeneration	7.29e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KDR—age related macular degeneration	7.15e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOE—age related macular degeneration	6.98e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL2—age related macular degeneration	6.92e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KDR—age related macular degeneration	6.84e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL2—age related macular degeneration	6.65e-05	9.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL2—age related macular degeneration	6.45e-05	9.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL2—age related macular degeneration	6.14e-05	9.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL2—age related macular degeneration	5.87e-05	8.83e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CD36—age related macular degeneration	5.49e-05	8.25e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—age related macular degeneration	4.84e-05	7.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LIPC—age related macular degeneration	4.66e-05	7e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CETP—age related macular degeneration	4.49e-05	6.76e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—age related macular degeneration	4.44e-05	6.68e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CD36—age related macular degeneration	4.38e-05	6.59e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—age related macular degeneration	4.27e-05	6.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—age related macular degeneration	4.14e-05	6.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—age related macular degeneration	3.94e-05	5.92e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—age related macular degeneration	3.87e-05	5.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—age related macular degeneration	3.77e-05	5.67e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CD36—age related macular degeneration	2.7e-05	4.06e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—age related macular degeneration	2.38e-05	3.58e-05	CbGpPWpGaD
